| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |